NPAS2 Antibodies

Santa Cruz Biotechnology provides a broad selection of NPAS2 monoclonal antibodies for investigating the biological functions of NPAS2 (Neuronal PAS Domain Protein 2). NPAS2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NPAS2 functions as a key transcription factor involved in the regulation of circadian rhythms and neuronal function. NPAS2 plays a crucial role in the modulation of gene expression in response to environmental cues, influencing processes such as sleep-wake cycles and metabolic regulation. Research has shown that NPAS2 significantly impacts various neurological disorders and metabolic diseases. Scientists can utilize NPAS2 monoclonal antibodies to explore molecular pathways and cellular mechanisms. Investigating NPAS2 expression patterns and interactions helps reveal its role in maintaining circadian rhythm homeostasis. Understanding NPAS2's function continues to provide valuable insights into neurological and metabolic conditions. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of NPAS2's role in health and disease.